128 related articles for article (PubMed ID: 30221677)
1. Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequencing.
Zhang L; Yu S; Wang C; Jia C; Lu Z; Chen J
Int J Oncol; 2018 Dec; 53(6):2659-2670. PubMed ID: 30221677
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway.
Li X; Deng SJ; Zhu S; Jin Y; Cui SP; Chen JY; Xiang C; Li QY; He C; Zhao SF; Chen HY; Niu Y; Liu Y; Deng SC; Wang CY; Zhao G
Oncotarget; 2016 Feb; 7(5):6000-14. PubMed ID: 26755660
[TBL] [Abstract][Full Text] [Related]
3. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma.
Liu P; Yang H; Zhang J; Peng X; Lu Z; Tong W; Chen J
Sci Rep; 2017 Jul; 7(1):5186. PubMed ID: 28701723
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1.
Kent OA; Mendell JT; Rottapel R
Mol Cancer Res; 2016 Mar; 14(3):267-77. PubMed ID: 26747707
[TBL] [Abstract][Full Text] [Related]
5. KRAS-related long noncoding RNAs in human cancers.
Saliani M; Mirzaiebadizi A; Javadmanesh A; Siavoshi A; Ahmadian MR
Cancer Gene Ther; 2022 May; 29(5):418-427. PubMed ID: 34489556
[TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
Müller S; Raulefs S; Bruns P; Afonso-Grunz F; Plötner A; Thermann R; Jäger C; Schlitter AM; Kong B; Regel I; Roth WK; Rotter B; Hoffmeier K; Kahl G; Koch I; Theis FJ; Kleeff J; Winter P; Michalski CW
Mol Cancer; 2015 Apr; 14():94. PubMed ID: 25910082
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.
Karmakar S; Kaushik G; Nimmakayala R; Rachagani S; Ponnusamy MP; Batra SK
Semin Cancer Biol; 2019 Feb; 54():63-71. PubMed ID: 29199014
[TBL] [Abstract][Full Text] [Related]
8. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.
Rachagani S; Macha MA; Menning MS; Dey P; Pai P; Smith LM; Mo YY; Batra SK
Oncotarget; 2015 Nov; 6(37):40295-309. PubMed ID: 26516699
[TBL] [Abstract][Full Text] [Related]
9. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
Liu R; Li J; Lai Y; Liao Y; Liu R; Qiu W
Int J Biol Macromol; 2015 Nov; 81():491-7. PubMed ID: 26275461
[TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA LINC01420 Contributes to Pancreatic Cancer Progression Through Targeting KRAS Proto-oncogene.
Zhai H; Zhang X; Sun X; Zhang D; Ma S
Dig Dis Sci; 2020 Apr; 65(4):1042-1052. PubMed ID: 31562613
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
[TBL] [Abstract][Full Text] [Related]
12. EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis.
Tanaka M; Suzuki HI; Shibahara J; Kunita A; Isagawa T; Yoshimi A; Kurokawa M; Miyazono K; Aburatani H; Ishikawa S; Fukayama M
Oncogene; 2014 May; 33(19):2454-63. PubMed ID: 23752186
[TBL] [Abstract][Full Text] [Related]
13. ARID1A suppresses malignant transformation of human pancreatic cells via mediating senescence-associated miR-503/CDKN2A regulatory axis.
Li ZY; Zhu SS; Chen XJ; Zhu J; Chen Q; Zhang YQ; Zhang CL; Guo TT; Zhang LM
Biochem Biophys Res Commun; 2017 Nov; 493(2):1018-1025. PubMed ID: 28942143
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer.
Jin X; Sun Y; Yang H; Li J; Yu S; Chang X; Lu Z; Chen J
PLoS One; 2015; 10(4):e0125515. PubMed ID: 25905463
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of long noncoding RNA-associated competing endogenous RNA network in periodontitis.
Li S; Liu X; Li H; Pan H; Acharya A; Deng Y; Yu Y; Haak R; Schmidt J; Schmalz G; Ziebolz D
J Periodontal Res; 2018 Aug; 53(4):495-505. PubMed ID: 29516510
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
[TBL] [Abstract][Full Text] [Related]
17. A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer.
Yao K; Wang Q; Jia J; Zhao H
Tumour Biol; 2017 Jun; 39(6):1010428317707882. PubMed ID: 28639886
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
Chen M; Lin M; Wang X
Oncol Rep; 2018 Feb; 39(2):619-626. PubMed ID: 29207158
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
Fu X; Cui Y; Yang S; Xu Y; Zhang Z
Tumour Biol; 2016 May; 37(5):6477-83. PubMed ID: 26631045
[TBL] [Abstract][Full Text] [Related]
20. The KRAS/Lin28B axis maintains stemness of pancreatic cancer cells via the let-7i/TET3 pathway.
Liu Y; Wang D; Zhou M; Chen H; Wang H; Min J; Chen J; Wu S; Ni X; Zhang Y; Gong A; Xu M
Mol Oncol; 2021 Jan; 15(1):262-278. PubMed ID: 33107691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
